Brief: Botanix Pharmaceuticals Signs Debt Facility With Kreos Capital
10/06/2025 02:45
June 10 (Reuters) - Botanix Pharmaceuticals Ltd BOT.AX: BOTANIX SIGNS DEBT FACILITY WITH KREOS CAPITAL SIGNS A$48 MILLION DEBT FACILITY WITH KREOS CAPITAL DEBT FACILITY TO SUPPORT SOFDRA COMMERCIALISATION AND PLATFORM EXPANSION Further company coverage: BOT.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Botanix Pharmaceuticals
See all newsBrief: Botanix Pharmaceuticals Receives Notice Of Allowance For Additional US Patent Covering Sofdra Drug Substance
Brief: Botanix Pharmaceuticals Appoints Paul Seaback As Chief Operating Officer
Brief: Botanix Pharmaceuticals Reaches Term Sheet Agreement With Second API Supplier
Botanix Pharmaceuticals jumps on supply agreement with PPL Pharma Solutions
Brief: Botanix Pharmaceuticals Posts HY Loss Attributable A$33.2 Million